✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Beryl Drugs Ltd.

BERLDRG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹11 Cr.
P/E
18.39

Beryl Drugs Ltd.

  • Beryl Drugs
  • Unjha Formulations
  • Colinz Laboratories
FAQs on Beryl Drugs Ltd. Shareprice

Beryl Drugs has given lower returns compared to its competitors.
Beryl Drugs has grown at ~-0.98% over the last 9yrs while peers have grown at a median rate of 15.81%

Beryl Drugs is not expensive.
Latest PE of Beryl Drugs is 18.39, while 3 year average PE is 22.56.
Also latest EV/EBITDA of Beryl Drugs is 5.4 while 3yr average is 8.58.

View FAQ's On Business
Growth Table
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Balance Sheet
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Cash Flow
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Quarterly Results
  • Beryl Drugs Ltd.
  • Unjha Formulations
  • Colinz Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Beryl Drugs Ltd. Financials

Balance sheet of Beryl Drugs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Beryl Drugs is decreasing.
Latest net debt of Beryl Drugs is ₹3.26 Crs as of Mar-25.
This is less than Mar-24 when it was ₹4.75 Crs.

The profit is oscillating.
The profit of Beryl Drugs is ₹0.58 Crs for TTM, ₹0.77 Crs for Mar 2024 and ₹0.77 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beryl Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech